Thomas Gayner - Markel Asset Management

Holding/activity history for  Teva Pharmaceutical Industries Ltd. (TEVA)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2014   Q4 0 0 Sell 100.00% 0.67
2014   Q3 444,000 0.67 Reduce 36.02% 0.38 $53.75
2014   Q2 694,000 1.04 $52.42
2014   Q1 694,000 1.13 Reduce 0.84% 0.01 $52.84
2013   Q4 699,900 0.89 Reduce 0.01% 0.00 $40.08
2013   Q3 700,000 0.91 Add 0.14% 0.00 $37.78
2013   Q2 699,000 0.98 Add 5.33% 0.05 $39.20
2013   Q1 663,600 0.98 Add 3.03% 0.03 $39.68
2012   Q4 644,100 1.00 Add 8.12% 0.08 $37.34
2012   Q3 595,700 1.05 Add 7.62% 0.07 $41.41
2012   Q2 553,500 1.00 Add 3.15% 0.03 $39.44
2012   Q1 536,600 1.11 Add 14.63% 0.14 $45.06
2011   Q4 468,100 1.00 Add 38.41% 0.28 $40.36
2011   Q3 338,200 0.77 Add 34.15% 0.20 $37.22
2011   Q2 252,100 0.65 Add 76.79% 0.28 $48.22
2011   Q1 142,600 0.39 Add 17.27% 0.06 $50.17
2010   Q4 121,600 0.35 Add 35.87% 0.09 $52.13
2010   Q3 89,500 0.28 Add 48.67% 0.09 $52.75
2010   Q2 60,200 0.21 Add 0.50% 0.00 $51.99
2010   Q1 59,900 0.23 Buy 0.23 $63.07